The molecular mechanisms involved in resistance to 5-fluorouracil (5-FU) in colon cancer patients remain to be elucidated. The purpose of this study was to identify proteins associated with 5-FU resistance in colon cancer.
Methods and study design
Proteins secreted from a 5-FU-resistant human colon cancer cell line (SNU-C4 5-FU 200) were analyzed by two-dimensional gel electrophoresis-based proteomics, and identified using matrix-associated laser desorption/ionization-mass spectroscopy analysis and SWISS-PROT database searches. The expression levels of candidate proteins were determined by Western blotting and cell proliferation was monitored by MTT assay.
Results
Chaperonin 10 (cpn10) was secreted at a lower level by 5-FU-resistant cells compared to the non-resistant parent cell line. The proliferation of both the parent and 5-FU-resistant cell lines increased slightly when extracellular cpn10 alone was added. However, in the presence of 5-FU, cpn10 augmented 5-FU-induced apoptotic death in both cell lines. Cpn10 led to activation of extracellular signal-regulated kinase 1/2 (ERK 1/2), and a specific ERK 1/2 inhibitor, PD98059, completely inhibited cpn10-stimulated cell proliferation.
Conclusions
Our findings indicate that concurrent treatment with cpn10 and 5-FU warrants further investigation in an effort to overcome 5-FU resistance and enhance the efficacy of 5-FU therapy for colon cancer.
SobreroA.F., AscheleC., BertinoJ.R.: Fluorouracil in colorectal cancer-a tale of two drugs: implications for biochemical modulation.J Clin Oncol, 15: 368–381, 1997.
ChoiC.H., KimW.D., LeeS.J., ParkW.Y.: Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer.Radiat Oncol J, 30: 99–107, 2012.
4.
YooB.C., JeonE., HongS.H., ShinY.K., ChangH.J., ParkJ.G.: Metabotropic glutamate receptor 4-mediated 5-fluorouracil resistance in a human colon cancer cell line.Clin Cancer Res, 10: 4176–4184, 2004.
5.
YeoS.G., KimD.Y., KimK.H., KuJ.L., KimJ.S., ChoM.J., KimE.S., YooB.C.: Hydroxymethylglutaryl-coenzyme A synthase 2 expression is associated with chemoradiotherapy responses in colorectal cancer.Dis Colon Rectum, 55: 686–694, 2012.
6.
GethingM.J., SambrookJ.: Protein folding in the cell.Nature, 355: 33–45, 1992.
7.
HemmingsenS.M., WoolfordC., van der ViesS.M., TillyK., DennisD.T., GeorgopoulosC.P., HendrixR.W., EllisR.J.: Homologous plant and bacterial proteins chaperone oligomeric protein assembly.Nature, 333: 330–334, 1988.
8.
WangW., VinocurB., ShoseyovO., AltmanA.: Role of plant heat-shock proteins and molecular chaperones in the abiotic stress response.Trends Plant Sci, 9: 244–252, 2004.
9.
CavanaghA.C., MortonH.: The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10.Eur J Biochem, 222: 551–560, 1994.
10.
CappelloF., DavidS., RappaF., BucchieriF., MarasaL., BartolottaT.E., FarinaF., ZummoG.: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastases.BMC Cancer, 5: 139, 2005.
11.
CorraoS., CampanellaC., AnzaloneR., FarinaF., ZummoG., Conway de MacarioE., MacarioA.J., CappelloF., La RoccaG.: Human Hsp10 and Early Pregnancy Factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives.Life Sci, 86: 145–152, 2010.
12.
YooB.C., KuJ.L., HongS.H., ShinY.K., ParkS.Y., KimH.K., ParkJ.G.: Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines.Int J Cancer, 108: 532–539, 2004.
13.
BradfordM.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem, 72: 248–254, 1976.
14.
ShinY.K., YooB.C., ChangH.J., JeonE., HongS.H., JungM.S., LimS.J., ParkJ.G.: Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.Cancer Res, 65: 3162–3170, 2005.
15.
LauS., PatnaikN., SayenM.R., MestrilR.: Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury.Circulation, 96: 2287–2294, 1997.
16.
KirchhoffS.R., GuptaS., KnowltonA.A.: Cytosolic heat shock protein 60, apoptosis, and myocardial injury.Circulation, 105: 2899–2904, 2002.
17.
ToddM.J., ViitanenP.V., LorimerG.H.: Dynamics of the chaperonin ATPase cycle: implications for facilitated protein folding.Science, 265: 659–666, 1994.
18.
CappelloF., BellafioreM., DavidS., AnzaloneR., ZummoG.: Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix.Cancer Lett, 196: 35–41, 2003.
19.
CappelloF., RappaF., DavidS., AnzaloneR., ZummoG.: Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis.Anticancer Res, 23: 1325–1331, 2003.
20.
GhobrialI.M., McCormickD.J., KaufmannS.H., LeontovichA.A., LoegeringD.A., DaiN.T., KrajnikK.L., StensonM.J., MelhemM.F., NovakA.J., AnsellS.M., WitzigT.E.: Proteomic analysis of mantle-cell lymphoma by protein microarray.Blood, 105: 3722–3730, 2005.
21.
TetuB., PopaI., BairatiI., L'EsperanceS., BachvarovaM., PlanteM., HarelF., BachvarovD.: Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas.Modern Pathol, 21: 1002–1010, 2008.
22.
AlessiD.R., CuendaA., CohenP., DudleyD.T., SaltielA.R.: PD 098059 is a specific inhibitor of the activation of mitogenactivated protein kinase kinase in vitro and in vivo.J Biol Chem, 270: 27489–27494, 1995.
23.
CrewsC.M., AlessandriniA., EriksonR.L.: The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product.Science, 258: 478–480, 1992.
24.
RosenL.B., GintyD.D., WeberM.J., GreenbergM.E.: Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras.Neuron, 12: 1207–1221, 1994.
25.
HoshinoR., ChataniY., YamoriT., TsuruoT., OkaH., YoshidaO., ShimadaY., Ari-iS., WadaH., FujimotoJ., KohnoM.: Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors.Oncogene, 18: 813–822, 1999.
26.
GioeliD., MandellJ.W., PetroniG.R., FriersonH.F.Jr., WeberM.J.: Activation of mitogen-activated protein kinase associated with prostate cancer progression.Cancer Res, 59: 279–284, 1999.
27.
CagnolS., ChambardJ.C.: ERK and cell death: mechanisms of ERK-induced cell death – apoptosis, autophagy and senescence.FEBS J, 277: 2–21, 2010.
